Español
Français
Deutsch
عربى
Jul 01,2022
Zhejiang Wantaifu Biotechnology Co.,Ltd. was officially settled in Hangzhou Bay Biotechnology Park of Xiaoshan Science and Technology City on September 13. Zhewei Sun, deputy director of Xiaoshan Science and Technology City Administration, attended.
At the ceremony, Mr. Hongyan Guan, Chairman of Wantaifu Biotechnology, expressed his gratitude to the guests, saying that it took just three months for Wantaifu Biotechnology to formally open from site selection, registration, decoration, acceptance to official opening, and such an efficient presentation is inseparable from the continuous support and cultivation policies of the Development Zone and Science and Technology City Administration for the biomedical industry, especially the leadership and staff of Xiaoshan Science and Technology City Administration responsible for investment attraction. This fully reflects the efficient and competent work style of the government in attracting investment. Wantaifu Biotechnology will forge ahead and live up to the expectations of the public, with the mission of "pursuing innovation and leading the future", so that life and health and precision medicine are within reach.
Zhewei Sun, deputy director of Xiaoshan Science and Technology City Administration, said that "life and health" is one of the three pillar industries that Xiaoshan focuses on, and Xiaoshan Science and Technology City is responsible for the two major chains of biotechnology innovation chain and medical device industry chain. We hope that Wantaifu Biotechnology will produce more scientific research results, get more product approvals and develop vigorously in this hot ground of Xiaoshan. Xiaoshan Science and Technology City will also continue to care about and support the development of enterprises, continue to build more open platforms and carriers, provide more perfect supporting services, create a more high-quality business environment, and promote mutual benefit and win-win situation between enterprises and the city.
Zhejiang Wantaifu Biotechnology Co.,Ltd. was incorporated on May 5, 2022, with a registered capital of 30 million yuan and a total investment of 100 million yuan, and is a biotechnology enterprise specializing in the research and development, production and sales of rapid diagnostic reagents and health products. It is not only convenient for customers to make flexible customization and design processing for precision consumables, but also can ensure the continuous supply of the supply chain.
At present, the company is developing and approving the following main products: automatic extraction instruments, portable oxygen concentrators, automatic fluorescence quantitative PCR instruments, new coronavirus detection kits, new coronavirus antigen detection kits, new coronavirus antibody detection kits, virus sampling tubes; cartridge tips and new coronavirus antigen, monkey pox virus, influenza virus, syncytial virus, adenovirus, pneumocystis; in addition There are also H. pylori, norovirus antigen detection kits, rotavirus & adenovirus dual detection virus detection kits, and world Alzheimer's disease detection kits.
Wantaifu Biotechnology will always adhere to science and technology as the guide and quality as the life, and is committed to providing better quality products, creating higher value and building a better life for the world, the society and the people.
